Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

Hepatology (Baltimore, Md.) - 1 Nov 2002

Wirth Stefan, Lang Thomas, Gehring Stephan, Gerner Patrick

Abstract excerpt

Treatment with alfa-interferon alone yielded poor results in children with chronic hepatitis C and was not generally recommended. Owing to limited experience with combination therapy in children, the aim of the study was to evaluate the efficacy and tolerability of alfa-interferon 2b in combination with ribavirin in these patients with different routes of viral transmission. In an uncontrolled pilot study, 41...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemoglobins

Share to Hepatitis C, Chronic

Share to Interferon Type I

Share to Pilot Projects

Share to Ribavirin

Share to Transaminases

Source

Identifiers

PMID: 12395341
DOI: 10.1053/jhep.2002.36495

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.PMID 12395341Read ↗

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.Semantic proximity Read ↗

Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.Semantic proximity Read ↗

Treatment for chronic hepatitis C in children: a review.Semantic proximity Read ↗

Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children.Semantic proximity Read ↗

Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children.Semantic proximity Read ↗

Management strategies for hepatitis C virus infection in children.Semantic proximity Read ↗

Management of Hepatitis C in Children - A New Paradigm.Semantic proximity Read ↗

Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation.Semantic proximity Read ↗

Interferon-α plus ribavirin yields 98 % sustained virologic response in children aged 1-5 years with iatrogenic chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C Virus in Children: Deferring Treatment in Expectation of Direct-Acting Antiviral Agents.Semantic proximity Read ↗

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.Semantic proximity Read ↗

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.